GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hualan Biological Engineering Inc (SZSE:002007) » Definitions » PB Ratio

Hualan Biological Engineering (SZSE:002007) PB Ratio : 2.52 (As of Mar. 27, 2025)


View and export this data going back to 2004. Start your Free Trial

What is Hualan Biological Engineering PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-03-27), Hualan Biological Engineering's share price is ¥16.09. Hualan Biological Engineering's Book Value per Share for the quarter that ended in Sep. 2024 was ¥6.40. Hence, Hualan Biological Engineering's PB Ratio of today is 2.52.

The historical rank and industry rank for Hualan Biological Engineering's PB Ratio or its related term are showing as below:

SZSE:002007' s PB Ratio Range Over the Past 10 Years
Min: 2.25   Med: 6.63   Max: 18.21
Current: 2.51

During the past 13 years, Hualan Biological Engineering's highest PB Ratio was 18.21. The lowest was 2.25. And the median was 6.63.

SZSE:002007's PB Ratio is ranked worse than
51.79% of 1282 companies
in the Biotechnology industry
Industry Median: 2.395 vs SZSE:002007: 2.51

During the past 12 months, Hualan Biological Engineering's average Book Value Per Share Growth Rate was 7.00% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 14.60% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 15.50% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 14.50% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Hualan Biological Engineering was 72.80% per year. The lowest was 8.50% per year. And the median was 15.75% per year.

Back to Basics: PB Ratio


Hualan Biological Engineering PB Ratio Historical Data

The historical data trend for Hualan Biological Engineering's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hualan Biological Engineering PB Ratio Chart

Hualan Biological Engineering Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.54 10.24 6.38 3.97 3.56

Hualan Biological Engineering Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.71 3.56 3.17 2.57 2.80

Competitive Comparison of Hualan Biological Engineering's PB Ratio

For the Biotechnology subindustry, Hualan Biological Engineering's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hualan Biological Engineering's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hualan Biological Engineering's PB Ratio distribution charts can be found below:

* The bar in red indicates where Hualan Biological Engineering's PB Ratio falls into.


;
;

Hualan Biological Engineering PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Hualan Biological Engineering's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Sep. 2024)
=16.09/6.396
=2.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Hualan Biological Engineering  (SZSE:002007) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Hualan Biological Engineering PB Ratio Related Terms

Thank you for viewing the detailed overview of Hualan Biological Engineering's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Hualan Biological Engineering Business Description

Traded in Other Exchanges
N/A
Address
No. 1, Hualan Avenue, Henan Province, Xinxiang, CHN, 453003
Hualan Biological Engineering Inc is a China-based biopharmaceutical company. It is engaged in the research, development, production, and commercialization of plasma products, viral vaccines, bacterial vaccines, and recombinant proteins and other biologics. The plasma products offered by the company include Human albumin, Human fibrinogen, Human tetanus immunoglobulin and others. The vaccines products include Recombinant hepatitis B vaccine, Inactivated influenza vaccine and other. It also offers gene products such as Monoclonal Antibody for tumor, autoimmune diseases, infectious diseases, transplant rejection, and Recombinant monoclonal antibodies.
Executives
Chen Zheng Yue Executives
Fan Bei Directors, executives
Pan Ruo Wen Executives
Xie Jun Min Directors, executives
An Wen Qi Executives
An Kang Directors, executives
Ma Xiao Wei Executives
Zhang Bao Xian Executives
An Wen Jue Director
Liu Jun Executives
Wang Qi Ping Directors, executives
Lv Cheng Yu Securities Affairs Representative
Zhang Jin Gang Independent director
Wang Li Ting Independent director
Ma Li Supervisors

Hualan Biological Engineering Headlines

No Headlines